Hillhouse leads $160m Series B funding in Chinese biopharma firm Genor

Hillhouse leads $160m Series B funding in Chinese biopharma firm Genor

Photo by Louis Reed on Unsplash

Chinese clinical-stage biopharmaceutical firm Genor Biopharma on Monday announced that it has garnered $160 million in a Series B round of financing led by Asia-focused private equity major Hillhouse Capital Group.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter